HEADER TRANSFERASE/INHIBITOR 20-JUN-12 4FOC TITLE CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH TITLE 2 ACYLIMINOBENZIMIDAZOLE INHIBITOR 2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALK TYROSINE KINASE RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 1058-1410; COMPND 5 SYNONYM: ANAPLASTIC LYMPHOMA KINASE; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ALK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS RECEPTOR TYROSINE KINASE, INHIBITOR, CRIZOTINIB, NEUROBLASTOMA, KEYWDS 2 CD246, PHOSPHOTRANSFERASE, NPM-ALK, EML4-ALK, IN SITU PROTEOLYSIS, KEYWDS 3 TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.A.WHITTINGTON,L.F.EPSTEIN,H.CHEN REVDAT 3 28-FEB-24 4FOC 1 REMARK SEQADV REVDAT 2 15-AUG-12 4FOC 1 JRNL REVDAT 1 11-JUL-12 4FOC 0 JRNL AUTH R.T.LEWIS,C.M.BODE,D.M.CHOQUETTE,M.POTASHMAN,K.ROMERO, JRNL AUTH 2 J.C.STELLWAGEN,Y.TEFFERA,E.MOORE,D.A.WHITTINGTON,H.CHEN, JRNL AUTH 3 L.F.EPSTEIN,R.EMKEY,P.S.ANDREWS,V.L.YU,D.C.SAFFRAN,M.XU, JRNL AUTH 4 A.DREW,P.MERKEL,S.SZILVASSY,R.L.BRAKE JRNL TITL THE DISCOVERY AND OPTIMIZATION OF A NOVEL CLASS OF POTENT, JRNL TITL 2 SELECTIVE, AND ORALLY BIOAVAILABLE ANAPLASTIC LYMPHOMA JRNL TITL 3 KINASE (ALK) INHIBITORS WITH POTENTIAL UTILITY FOR THE JRNL TITL 4 TREATMENT OF CANCER. JRNL REF J.MED.CHEM. V. 55 6523 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22734674 JRNL DOI 10.1021/JM3005866 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 35324 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1772 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2239 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.92 REMARK 3 BIN R VALUE (WORKING SET) : 0.2810 REMARK 3 BIN FREE R VALUE SET COUNT : 138 REMARK 3 BIN FREE R VALUE : 0.3190 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2333 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 318 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.05000 REMARK 3 B22 (A**2) : -0.45000 REMARK 3 B33 (A**2) : 0.40000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.112 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.110 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.074 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.211 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.949 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2429 ; 0.007 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 1697 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3294 ; 1.195 ; 1.990 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4088 ; 0.860 ; 3.003 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 293 ; 5.123 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 107 ;33.196 ;23.738 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 405 ;12.409 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 17 ;19.988 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 356 ; 0.071 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2661 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 481 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4FOC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-JUN-12. REMARK 100 THE DEPOSITION ID IS D_1000073150. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35440 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.10 REMARK 200 R MERGE FOR SHELL (I) : 0.64800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 5000 MONOMETHYL ETHER, 200 MM REMARK 280 AMMONIUM SULFATE, 2 MM DITHIOTHREITOL, 100 MM MES (PH 6.5) - 1: REMARK 280 200 (W/W) CHYMOTRYPSIN:ALK, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.84300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.71600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.75250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.71600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.84300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.75250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 1058 REMARK 465 TYR A 1059 REMARK 465 ARG A 1060 REMARK 465 ARG A 1061 REMARK 465 LYS A 1062 REMARK 465 HIS A 1063 REMARK 465 GLN A 1064 REMARK 465 GLU A 1065 REMARK 465 LEU A 1066 REMARK 465 GLN A 1067 REMARK 465 ALA A 1068 REMARK 465 MET A 1069 REMARK 465 GLN A 1070 REMARK 465 MET A 1071 REMARK 465 GLU A 1072 REMARK 465 LEU A 1073 REMARK 465 GLN A 1074 REMARK 465 SER A 1075 REMARK 465 PRO A 1076 REMARK 465 GLU A 1077 REMARK 465 TYR A 1078 REMARK 465 LYS A 1079 REMARK 465 LEU A 1080 REMARK 465 SER A 1081 REMARK 465 LYS A 1082 REMARK 465 LEU A 1083 REMARK 465 ARG A 1084 REMARK 465 THR A 1085 REMARK 465 SER A 1086 REMARK 465 THR A 1087 REMARK 465 ILE A 1088 REMARK 465 MET A 1089 REMARK 465 THR A 1090 REMARK 465 ASP A 1091 REMARK 465 TYR A 1092 REMARK 465 GLY A 1137 REMARK 465 MET A 1138 REMARK 465 PRO A 1139 REMARK 465 ASN A 1140 REMARK 465 ASP A 1141 REMARK 465 PRO A 1142 REMARK 465 ALA A 1280 REMARK 465 SER A 1281 REMARK 465 TYR A 1282 REMARK 465 TYR A 1283 REMARK 465 ARG A 1284 REMARK 465 LYS A 1285 REMARK 465 GLY A 1286 REMARK 465 GLY A 1287 REMARK 465 PRO A 1403 REMARK 465 LEU A 1404 REMARK 465 VAL A 1405 REMARK 465 GLU A 1406 REMARK 465 GLU A 1407 REMARK 465 GLU A 1408 REMARK 465 GLU A 1409 REMARK 465 LYS A 1410 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A1127 -155.90 -74.13 REMARK 500 ARG A1248 -3.50 78.50 REMARK 500 ASP A1249 52.54 -154.47 REMARK 500 MET A1302 -61.57 -99.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0UU A 1501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4FNW RELATED DB: PDB REMARK 900 RELATED ID: 4FNX RELATED DB: PDB REMARK 900 RELATED ID: 4FNY RELATED DB: PDB REMARK 900 RELATED ID: 4FNZ RELATED DB: PDB REMARK 900 RELATED ID: 4FOB RELATED DB: PDB REMARK 900 RELATED ID: 4FOD RELATED DB: PDB DBREF 4FOC A 1058 1410 UNP Q9UM73 ALK_HUMAN 1058 1410 SEQADV 4FOC SER A 1097 UNP Q9UM73 CYS 1097 ENGINEERED MUTATION SEQRES 1 A 353 VAL TYR ARG ARG LYS HIS GLN GLU LEU GLN ALA MET GLN SEQRES 2 A 353 MET GLU LEU GLN SER PRO GLU TYR LYS LEU SER LYS LEU SEQRES 3 A 353 ARG THR SER THR ILE MET THR ASP TYR ASN PRO ASN TYR SEQRES 4 A 353 SER PHE ALA GLY LYS THR SER SER ILE SER ASP LEU LYS SEQRES 5 A 353 GLU VAL PRO ARG LYS ASN ILE THR LEU ILE ARG GLY LEU SEQRES 6 A 353 GLY HIS GLY ALA PHE GLY GLU VAL TYR GLU GLY GLN VAL SEQRES 7 A 353 SER GLY MET PRO ASN ASP PRO SER PRO LEU GLN VAL ALA SEQRES 8 A 353 VAL LYS THR LEU PRO GLU VAL CYS SER GLU GLN ASP GLU SEQRES 9 A 353 LEU ASP PHE LEU MET GLU ALA LEU ILE ILE SER LYS PHE SEQRES 10 A 353 ASN HIS GLN ASN ILE VAL ARG CYS ILE GLY VAL SER LEU SEQRES 11 A 353 GLN SER LEU PRO ARG PHE ILE LEU LEU GLU LEU MET ALA SEQRES 12 A 353 GLY GLY ASP LEU LYS SER PHE LEU ARG GLU THR ARG PRO SEQRES 13 A 353 ARG PRO SER GLN PRO SER SER LEU ALA MET LEU ASP LEU SEQRES 14 A 353 LEU HIS VAL ALA ARG ASP ILE ALA CYS GLY CYS GLN TYR SEQRES 15 A 353 LEU GLU GLU ASN HIS PHE ILE HIS ARG ASP ILE ALA ALA SEQRES 16 A 353 ARG ASN CYS LEU LEU THR CYS PRO GLY PRO GLY ARG VAL SEQRES 17 A 353 ALA LYS ILE GLY ASP PHE GLY MET ALA ARG ASP ILE TYR SEQRES 18 A 353 ARG ALA SER TYR TYR ARG LYS GLY GLY CYS ALA MET LEU SEQRES 19 A 353 PRO VAL LYS TRP MET PRO PRO GLU ALA PHE MET GLU GLY SEQRES 20 A 353 ILE PHE THR SER LYS THR ASP THR TRP SER PHE GLY VAL SEQRES 21 A 353 LEU LEU TRP GLU ILE PHE SER LEU GLY TYR MET PRO TYR SEQRES 22 A 353 PRO SER LYS SER ASN GLN GLU VAL LEU GLU PHE VAL THR SEQRES 23 A 353 SER GLY GLY ARG MET ASP PRO PRO LYS ASN CYS PRO GLY SEQRES 24 A 353 PRO VAL TYR ARG ILE MET THR GLN CYS TRP GLN HIS GLN SEQRES 25 A 353 PRO GLU ASP ARG PRO ASN PHE ALA ILE ILE LEU GLU ARG SEQRES 26 A 353 ILE GLU TYR CYS THR GLN ASP PRO ASP VAL ILE ASN THR SEQRES 27 A 353 ALA LEU PRO ILE GLU TYR GLY PRO LEU VAL GLU GLU GLU SEQRES 28 A 353 GLU LYS HET 0UU A1501 35 HETNAM 0UU METHYL CIS-4-[2-(BENZOYLAMINO)-6-(PIPERIDIN-1- HETNAM 2 0UU YLMETHYL)-1H-BENZIMIDAZOL-1-YL]CYCLOHEXANECARBOXYLATE FORMUL 2 0UU C28 H34 N4 O3 FORMUL 3 HOH *318(H2 O) HELIX 1 1 SER A 1104 LEU A 1108 5 5 HELIX 2 2 PRO A 1112 LYS A 1114 5 3 HELIX 3 3 SER A 1157 PHE A 1174 1 18 HELIX 4 4 LEU A 1204 THR A 1211 1 8 HELIX 5 5 ALA A 1222 ASN A 1243 1 22 HELIX 6 6 ALA A 1251 ARG A 1253 5 3 HELIX 7 7 PHE A 1271 ARG A 1279 1 9 HELIX 8 8 PRO A 1292 MET A 1296 5 5 HELIX 9 9 PRO A 1297 GLY A 1304 1 8 HELIX 10 10 THR A 1307 SER A 1324 1 18 HELIX 11 11 SER A 1334 SER A 1344 1 11 HELIX 12 12 PRO A 1355 TRP A 1366 1 12 HELIX 13 13 GLN A 1369 ARG A 1373 5 5 HELIX 14 14 ASN A 1375 ASP A 1389 1 15 HELIX 15 15 ASP A 1389 ASN A 1394 1 6 SHEET 1 A 2 TYR A1096 PHE A1098 0 SHEET 2 A 2 LYS A1101 SER A1103 -1 O SER A1103 N TYR A1096 SHEET 1 B 5 ILE A1116 HIS A1124 0 SHEET 2 B 5 GLU A1129 VAL A1135 -1 O GLU A1132 N ILE A1119 SHEET 3 B 5 LEU A1145 THR A1151 -1 O VAL A1149 N TYR A1131 SHEET 4 B 5 PHE A1193 GLU A1197 -1 O LEU A1196 N ALA A1148 SHEET 5 B 5 CYS A1182 SER A1186 -1 N GLY A1184 O LEU A1195 SHEET 1 C 3 GLY A1202 ASP A1203 0 SHEET 2 C 3 CYS A1255 LEU A1257 -1 O LEU A1257 N GLY A1202 SHEET 3 C 3 ALA A1266 ILE A1268 -1 O LYS A1267 N LEU A1256 CISPEP 1 LEU A 1190 PRO A 1191 0 -4.95 SITE 1 AC1 10 GLY A1121 LEU A1122 VAL A1130 ALA A1148 SITE 2 AC1 10 LEU A1196 GLU A1197 MET A1199 LEU A1256 SITE 3 AC1 10 GLY A1269 HOH A1752 CRYST1 51.686 57.505 105.432 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019348 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017390 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009485 0.00000